ESC 2026: Common pharma excipient linked to uptick in cardiovascular risk - Pharmaceutical Technology

Researchers call for further exploration of xylitol’s impact on heart health as its use in food and pharma continues to rise. Researchers call for further exploration of xylitol’s impact on heart health as its use in food and pharma continues to rise. High blood levels of artificial sweetener, xylitol, could boost an individual’s risk of major cardiovascular events like heart attack and stroke, an observational analysis has found. Credit: NMK-Studio / Shutterstock.com. A long-term analysis has revealed that high blood levels of common artificial sweetener, xylitol, can be associated with a greater risk of cardiovascular events within the general population,…

Source: Pharmaceutical Technology